Objective: The acquired long QT syndrome results most often from the action of I blocking-drugs on cardiac repolarization. We have Kr evaluated a transgenic (TG) mouse (FVB) overexpressing a dominant-negative KvLQT1 isoform, as an in vivo screening model for I Kr blocking drugs. Results: In TG mice, six-lead ECGs demonstrated sinus bradycardia, atrioventricular block, and QTc prolongation. Various drugs were injected intraperitoneally after blockade of the autonomic nervous system and serial ECGs were recorded. The end of the initial rapid phase of the T wave corrected for heart rate using a formula for mouse heart (QTrc), was used as a surrogate for the QT interval. Dofetilide, a specific I blocker, did not prolong the QTrc interval either in TG or in wild-type (WT) mice but dose-dependently Kr lengthened the sinus period in TG mice but not in WT mice. Other I blockers including E 4031, haloperidol, sultopride, astemizole, Kr cisapride and terikalant behaved similarly to dofetilide. Tedisamil, a blocker of the transient outward current, dose-dependently prolonged the QTrc in WT mice but not in TG mice and also reduced the sinus rhythm in both WT and TG mice. Lidocaine dose-dependently shortened the QTrc interval in TG mice and also lengthened the P wave duration. Nicardipine dose-dependently shortened QTrc and also produced sinus arrest in both WT and TG mice. Conclusions: We conclude that KvLQT1-invalidated TG mice discriminates in vivo drugs that blocks I from drugs that block the transient outward current, the sodium current or the calcium current.
Introduction
LQT gene mutations revealed by drugs. Indeed, the LQT syndrome has a low penetrance with up to 70% of LQT The congenital long QT (LQT) syndrome is charactersilent gene carriers having normal QTc interval in some ised by a prolonged QT interval on the surface ECG, and is families [4, 5] . Silent gene carriers remain at high risk for most often related to mutations in KCNQ1, a gene sudden death, particularly after intake of one of the 1 encoding for KvLQT1 K channel proteins [1] . In concert numerous drugs that delayed cardiac repolarization [6] . with its regulator minK, KvLQT1 channel underlies the Most of these drugs alter cardiac repolarization by blockslow component of the cardiac delayed rectifier current I ing the fast component of the cardiac delayed rectifier Ks [2, 3] . It has been suggested that the acquired (drug-incurrent I . Their identification at a preclinical stage Kr duced) long QT syndrome matches with silent forms of remains a complex and challenging issue. In vitro testing can be conducted using action potential recordings and patch-clamp experiments [6] . In vivo testing exploring the effects of the parent compound but also of its metabolites 2.2. Surface electrocardiogram recording can be established using multilead ECG recordings. However, currently available in vivo models are unsatisfactory
To record surface ECGs, the mouse's four paws and (for a recent review see [6] ).
four Ag electrodes were plunged into eight Eppendorf We have established a transgenic (TG) mouse model in tubes, filled with KCl (2 mol / l) solution, and connected which KvLQT1 has been functionally invalidated by with KCl (2 mol / l) Agar bridges. The signal was amplified overexpression of its dominant negative isoform [7] . This and filtered (bandwidth, 0.5-125 Hz), and the cardiac ECG KvLQT1 mouse model shares some common features with was continuously monitored (Monitor 123, Roche, Biothe long QT syndrome in patients including long QT and Electronics, Digital Electronics). Surface six-lead ECGs (I, sinus node dysfunction [8, 9] . We hypothesised that trans-II, III, aVR, aVL, aVF) were displayed with a chart genic mice would be sensitised to the action of I recorder (Easy Graph, TA 240, Gould Electronics) at a Kr pharmacological blockers and therefore that the TG model paper speed of 100 mm / s. All reported measurements may demonstrate some value as an in vivo model to were averaged from five consecutive PQRST complexes in identify drugs that delay repolarization in human. Using lead I. [7] . In both WT and TG animals, the T wave had a standard ECG recordings, we found that drugs known to biphasic appearance with an initial rapid component (Tr alter cardiac repolarization in human do not prolong the positive in lead DI) and a late slower component (Ts QTc interval in TG mice but instead profoundly affect negative in lead DI). The rapid component Tr was sinus node automaticity in TG mice. Using various ECG markedly prolonged in the H08 lineage used for the parameters, we show that our transgenic LQT model present study. The P wave often superposed with the discriminates drugs that block I from drugs that block the terminal phase of the previous slower component of the T Kr transient outward current, the sodium current or the wave because of dramatic QT and PR lengthening (Fig. 1 ). calcium current.
For more accuracy, we considered the end of the Tr wave as a surrogate for the end of the T wave. The QTr interval was measured from the beginning of the QRS complex 2. Methods wave to the end of the Tr wave (Fig. 1) . The QTr interval was corrected for heart rate using the formula, QTrc5QTr [7] . Among these, a lineage with a phenotype of intermediary severity (H08 We used commercially available solutions for etomidate lineage) but with well-defined P and T waves, was selected (Janssen-Cilag), atropine sulphate (Renaudin), propanolol for the present study. The investigation conforms with the chlorhydrate (Zeneca Pharma), sultopride chlorhydrate Guide for the Care and Use of Laboratory Animals (Delagrange), lidocaine chlorhydrate (Aguettant), nicarpublished by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). All animals were 4-6 weeks-old (18-22 g) male and female TG mice, and age-and weight-matched littermate WT controls. Mice were anaesthetised with etomidate (15 mg / kg) given intraperitoneally (i.p.). They were placed under a heating lamp to prevent loss of body heat, which was continuously monitored with an electronic thermometer. The autonomic nervous system was blocked 5 min after anaesthesia using atropine sulphate (0.5 mg / kg i.p.) and propanolol (1 mg / kg i.p) [10] . A single dose of the drug under investigation was i.p. injected 10 min after anaesthesia. All drugs were given individually. The maximum effects of drugs as assessed by continuous ECG monitoring were observed at around 10 min post i.p. injection, and remained stable for dipine chlorhydrate (Novartis), and haloperidol (JanssenCilag). Dofetilide, E4031, terikalant, tedisamil, astemizole and cisapride were obtained as free bases. Atropine sulphate and propanolol were 1 / 3 diluted in 0.9% NaCl. Other solutions and hydrophilic free bases were diluted in HEPES Tyrode's solution at pH 5 and then buffered at pH 7.4 using NaOH. Prior dilution in acid water was performed for dofetilide. The final dilution was adjusted so that the injected volume per dose and per animal was always 300 ml. Hydrophobic drugs (astemizole and cisapride) were diluted in dimethylsulfoxide (Sigma), so that the injected volume per dose and per animal was always 25 ml.
Statistical analysis
All ECG data are presented as a mean6standard deviation. Mean data were compared using analysis of variance. If a statistically significant level was reached (P,0.05), a multiple comparison procedure (Fisher's PLSD test) was performed to determine which pair(s) of means were statistically different.
Results

Effects of I blockers
Kr
We first evaluated the effects of dofetilide, a wellestablished specific blocker of the I potassium current Kr [12, 13] . The dose-dependent effects of dofetilide were investigated in WT and TG mice. As shown in Fig. 2 , the PR interval in TG mice (P50.03) but not in WT mice. In TG mice, the PR interval shortening was dose-dependent, and paralleled the lengthening of the PP interval.
tively; P50.0001). We also investigated the effects of Various drugs known for their ability to block the I sultopride [16] (200 mg / kg), haloperidol [17] (7 mg / kg), Kr current and also to prolong the QT interval in human were astemizole [18] (10 mg / kg), and cisapride [19] (20 mg / further evaluated in the TG mouse model (Fig. 3) . In WT kg). Again, the effects induced by these drugs on WT and and TG mice, the effects of E4031 [14] (20 mg / kg) and of TG mice were comparable to those induced by more terikalant [15] (10 mg / kg) were similar to those produced specific I blockers. The PP interval prolongation was Kr by dofetilide. In particular, E4031 and terikalant did not also much greater in TG mice (1105%, 178%, 1183% prolong the QTrc duration either in WT or TG mice but and 1148%, with sultopride haloperidol, astemizole and induced a PP interval prolongation that was more procisapride, respectively) than in WT mice (122%, 16%, nounced in TG mice (1191% with E4031 and 196% with 115% and 136%; P,0.003). However, at the tested terikalant) than in WT mice (159% and 119%, respecdose, sultopride, haloperidol, astemizole, and cisapride did (vehicle) to 283657 ms (1153%; 50 mg / kg tedisamil) in WT mice, and from 136621 ms (vehicle) to 374697 ms not decrease significantly the PR interval in TG or WT (1175%) in TG mice. The P wave duration was slightly mice (not illustrated). No I blocking drug modified the P prolonged at the highest tedisamil dose in WT mice (P5 outward K current, I . As illustrated in Fig. 4 , tedisamil to lengthened the duration of the rapid phase of the T wave As shown in Fig. 5 , lidocaine dose-dependently shorboth in WT and TG mice. In WT mice, the shape of the T tened the QTrc interval in TG mice (from 4563 ms with wave under tedisamil mimicked that recorded in TG mice the vehicle to 3063 ms with lidocaine 80 mg / kg; P5 under control conditions (Fig. 4A) . In contrast to I 0.003), whereas the drug produced no significant effects on Kr blockers, tedisamil dose-dependently prolonged the QTrc the QTrc interval in WT mice. Lidocaine also prolonged interval in WT mice (from 1962 ms with the vehicle to the PP interval with a similar efficacy in WT (P50.0001) 3964 ms with 50 mg / kg tedisamil; P50.0001), an effect and TG (P50.0001) mice: the PP interval increased from not observed in TG mice (Fig. 4B) . In addition, tedisamil 112615 ms (vehicle) to 190639 ms (170%; 80 mg / kg dose-dependently prolonged the PP interval in both WT lidocaine) in WT mice, and from 136621 ms (vehicle) to the nicardipine-induced PP lengthening was more pro-240627 ms (176%) in TG mice. It should be noted, nounced in TG than in WT mice: the PP interval increased however, that the effects of lidocaine on the PP interval from 136621 ms (vehicle) to 4486124 ms (1229%; 10 essentially occurred at the highest drug dosage (Fig. 5) .
mg / kg nicardipine) in TG mice, whereas it increased from The most striking effect of lidocaine consisted in a dose-112615 ms (vehicle) to 210667 ms (188%) only in WT dependent P wave lengthening which was observed both in mice. Finally, we observed a dose-dependent QTrc short-WT and TG mice. The PR interval was also dose-depenening in both WT (from 1962 ms with the vehicle to dently prolonged by lidocaine in WT mice (P50.0001) 1061 ms with 10 mg / kg nicardipine; P50.0001) and TG whereas it was not significantly altered by the drug in TG mice (from 4563 ms to 2366 ms; P50.0001). By mice.
contrast, the P wave duration and the PR interval were not significantly altered by the drug. 21 
Effects of Ca channel block
Data obtained with nicardipine [21] are depicted in Fig.  4 . Discussion 6. The most remarkable effect of nicardipine consisted of a sinus arrest often preceded by isorhythmic dissociation
We have evaluated a KvLQT1-deficient transgenic (Fig. 6A) . In TG mice, sinus arrest occurred in most mouse, as a model suitable to identifying I blocking Kr animals for every tested dose. In WT mice, sinus arrest drugs. Our results show that combined in vivo pharmacooccurred at the highest dosage (10 mg / kg) only. Sinus logical investigation of wild-type and transgenic mice arrest under the effects of the drug was observed between discriminates drugs that blocks I from drugs that block Ca,L Kr to Na pendently prolonged the PP interval in both WT (P5 or I all decreased the sinus rate (Table 1) . However, I
Ca,L Kr 0.0001) and TG (P50.0001) mice. As with I blockers, blockers and nicardipine produce bradycardia preferenKr plays little or no role in pacemaker cells. In the rabbit sinus Table 1 node however, Kreitner [33] reported that pacemaker In contrast to the human heart, I does not contribute diastolic depolarisation and eventually abolish spontaneous Kr substantially to repolarization in adult mice [22] . In line activity [35] . A negative chronotropic effect of dihydrowith this, adult transgenic mice over-expressing a domipyridine has also been reported in various species whether nant-negative HERG mutated gene exhibit normal QT on isolated sinus node or atrial tissues, or perfused hearts. duration [23] . Furthermore, dofetilide does not prolong the In contrast, nicardipine shortens the sinus cycle length in QTc interval in normal adult mice (Ref. [24] and present humans [36] as a result of the adrenergic stimulation data). The contribution of I to the sinus node autorelated to the drop in blood pressure. In our study Kr maticity remains also modest in normal adult mice since performed under blockade of the autonomic nervous dofetilide produces bradycardia at high doses (.0.5 mg / system, nicardipine caused a dose-dependent lengthening kg) only (Ref. [24] and present data). In our transgenic of the PP interval in TG mice, and to a lesser extent in WT mice, we believe that functional suppression of I and / or mice. We propose that the I current contributes largely Ks Ca,L 1 remodeling of K channels [7] exacerbate the relative role to the sinus node automaticity in mouse. Again, in TG of I in pacemaking and result in a markedly increased mice, functional suppression of I and / or remodeling of In contrast to I , the transient outward current, I , is a sinus node to the bradycardic effects produced by nicarKr to dominant repolarising current in the adult mouse heart dipine. [25] . Functional suppression of Kv4.2 decreases the I The pharmacological profiles of I , I , I and I to Kr Na Ca,L to current amplitude, and prolongs both action potential and blockers in mice profoundly differs from those reported in QT interval durations in adult mice [26] . In normal mice, larger animals and in human. This is not surprising since 4-aminopyridine, a blocker of transient outward current the cellular electrophysiological characteristics of prolongs the QTc interval [24] . In our own experiments, myocytes from small size rodents including mice and rats tedisamil dose-dependently prolonged the QTrc in WT also markedly differ from those reported for larger animals mice but not in TG mice suggesting that the current and human. For example, I plays only a minor role Kr blocked by tedisamil was already down-regulated in TG during repolarization in the mouse [22] whereas this mice. In line with this, in TG mice we reported downcurrent is crucial for repolarization in the dog [37] and in expression of Kv 4.2 channels accompanied by a decreased the human heart [38] . In that setting, the cardiac repolari-I current density [7] . I , has been shown to contribute zation of either normal or transgenic mice is not sensitive to to also to sinoatrial automaticity in other species including to QT prolonging drugs, in stark contrast with the dog or the rabbit [27] and the rat [28] . In human, clinical studies the human heart. reported a bradycardic action of tedisamil [29] [30] [31] .
A decreased I window current is usually evoked to Na explain the action potential shortening as produced by
